mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.025 |
0.6 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.6 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.15 |
0.6 |